Milestone biodefense publication by Elsevier journal Vaccine
Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense. view more (2009-11-20)
Better immune defense against anthrax
Scientists discover a gene in anthrax-causing bacteria may help defend against this form of bio-warfare. view more (2009-09-09)
Early detection and quick response are key to defense against anthrax attack
A large attack on a major metropolitan area with airborne anthrax could affect more than a million people, necessitating their treatment with powerful antibiotics. view more (2009-07-27)
Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by the New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab. view more (2009-07-10)
Unexpected discovery can open a new chapter in the fight against tuberculosis
A close relative of the microorganism that causes tuberculosis in humans has been found to form spores. view more (2009-06-09)
Novel method predicts impact of a covert anthrax release
A new statistical method that can estimate the origin and time of an aerosolized release of the pathogen causing anthrax, following detection of the first few cases has been developed by researchers from the Medical Research Council (MRC) Centre for Outbreak Analysis and Modelling at Imperial College London in collaboration with the Health... view more... (2009-04-10)
Goodbye needle, hello smoothie
Instead of a dreaded injection with a needle, someday getting vaccinated against disease may be as pleasant as drinking a yogurt smoothie. view more (2009-03-18)
Good bacteria can be EZ Pass for oral vaccine against anthrax
Researchers at North Carolina State University have discovered that the good bacteria found in dairy products and linked to positive health benefits in the human body might also be an effective vehicle for an oral vaccine that can provide immunity to anthrax exposure. view more (2009-02-17)
Revisiting the anthrax attacks
When anthrax was sent through the U.S. Postal Service in 2001, an overwhelming majority of postal workers elected not to be inoculated with the available vaccine because of confusion and distrust, according to a University of Pittsburgh Graduate School of Public Health study. view more (2009-01-23)
Scientists Present 'Moving' Theory Behind Bacterial Decision-Making
Biochemists at North Carolina State University have answered a fundamental question of how important bacterial proteins make life-and-death decisions that allow them to function, a finding that could provide a new target for drugs to disrupt bacterial decision-making processes and related diseases. view more (2008-11-25)
Scripps research scientists identify blood component that turns bacteria virulent
Scientists from the Scripps Research Institute have discovered the key chemical that signals Bacillus anthracis, the bacterium that causes anthrax, to become lethal. This finding opens up new avenues of exploration for the development of treatments for bacterial infections. view more (2008-11-24)
Nature study demonstrates that bacterial clotting depends on clustering
Bacteria can directly cause human blood and plasma to clot-a process that was previously thought to have been lost during the course of vertebrate evolution, according to new research at the University of Chicago, National Institute of Allergy and Infectious Diseases, and Institut Pasteur in Paris. Their findings will be published online Nov. 2 in... view more... (2008-11-03)
Green catalysts provide promise for cleaning toxins and pollutants
Tetra-Amido Macrocyclic Ligands (TAMLs) are environmentally friendly catalysts with a host of applications for reducing and cleaning up pollutants, and a prime example of "green chemistry." Carnegie Mellon University's Terry Collins, the catalyst's inventor, believes that the small-molecule catalysts have the potential to be even more... view more... (2008-08-18)
Francisella tularensis: Stopping a biological weapon
Scientists hope a vaccine is on the horizon for tularemia, a fatal disease caused by the pathogen Francisella tularensis, an organism of concern as a potential biological warfare agent. Until recently we knew very little about this bacterium. view more (2008-07-28)
New strategies against bird flu
The Spanish flu outbreak of 1918 killed between 30 and 50 million people. In the infected patients, the ultimate cause of death was acute respiratory distress syndrome (ARDS). view more (2008-04-18)
NIST, Army researchers pave the way for anthrax spore standards
Researchers from the National Institute of Standards and Technology (NIST) and the U.S. Army Dugway (Utah) Proving Ground have developed reliable methods based on DNA analysis to assess the concentration and viability of anthrax spores after prolonged storage. view more (2008-04-16)
Protein data bank archives 50,000th molecule structure
The Protein Data Bank (PDB) based at Rutgers, The State University of New Jersey, and the University of California-San Diego (UCSD) this month reached a significant milestone in its 37-year history. The 50,000th molecule structure was released into its archive, joining other structures vital to pharmacology, bioinformatics and education. view more (2008-04-09)
Is a cup of tea really the answer to everything -- even anthrax?
A cup of black tea could be the next line of defence in the threat of bio-terrorism according to new international research. view more (2008-03-13)
Researchers find possible target to treat deadly bloodstream infections
Researchers at the University of Illinois at Chicago have discovered a possible target to treat bloodstream bacterial infections. view more (2008-02-29)
'Smart' holograms help patients help themselves
Patients with diabetes, cardiac problems, kidney disorders or high blood pressure could benefit from the development of new hologram technology. view more (2008-02-04)
|
|
